屋尘螨变应原特异性免疫治疗儿童哮喘的临床效果观察

详细信息    查看全文 | 推荐本文 |

英文篇名：Clinical Observation of House Dust Mite Allergen-specific Immunotherapy for Children with Asthma 作者：张庭辉 英文作者：ZHANG Ting-hui;Department of Pharmacy, Lianyungang Maternal and Child Health Hospital; 关键词：屋尘螨变应原制剂 ; 特异性 ; 免疫治疗 ; 儿童哮喘 英文关键词：House dust mite allergen preparation;;Specificity;;Immunotherapy;;Childhood asthma 中文刊名：SJFH 英文刊名：World Journal of Complex Medicine 机构：连云港市妇幼保健院药剂科; 出版日期：2019-01-15 出版单位：世界复合医学 年：2019 期：v.5 语种：中文; 页：SJFH201901043 页数：3 CN：01 ISSN：10-1273/R 分类号：136-138

摘要

目的探究儿童哮喘采用屋尘螨变应原特异性免疫治疗措施的临床疗效。方法选择2017年1月—2018年10月期间该院收治的儿童哮喘患者124例作为该次研究对象,利用随机法将患者分为治疗组与对照组,各62例,对照组患儿行常规治疗,治疗组患儿以此为基础行屋尘螨变应原制剂治疗,对比各组患儿治疗前后肺功能、哮喘症状评分,分析两组患儿治疗总有效率差异性。结果治疗组患儿肺功能评分、哮喘症状评分均高于对照组,差异有统计学意义(t=15.082 8、25.993 6、16.691 0,P<0.05),治疗组总有效率96.77%明显高于对照组85.48%,差异有统计学意义(χ~2=4.888 2,P=0.027 0<0.05)。结论儿童哮喘采用屋尘螨变应原特异性免疫治疗安全高效,值得推广。
        Objective To investigate the clinical efficacy of house dust mite allergenspecific immunotherapy in children with asthma.Methods A total of 124 children with asthma in our hospital from January 2017 to May 2018 were selected as the study subjects. The patients were divided into treatment group and control group by random method. All groups were 62 cases each. According to the routine treatment of children, the treatment group was treated with house dust mite allergen preparation. The lung function and asthma symptom scores of each group were compared before and after treatment. The total effective rate difference between the two groups was analyzed. Results The lung function score and asthma symptom score of the treatment group were higher than the control group,the difference was statistically significant(t=15.082 8, 25.993 6, 16.691 0, P<0.05). The total effective rate of the treatment group was 96.77%, which was significantly higher than that of the control group(85.48%),the different was statistically significant(χ~2=4.888 2,P=0.027 0<0.05). Conclusion Childhood asthma is safe and effective with house dust mite allergenspecific immunotherapy, which is worthy of promotion.

引文

[1]孙月眉,刘丽萍,邢海燕,等.儿童哮喘患者屋尘螨变应原集群免疫治疗与常规免疫治疗起始阶段的安全性[J].中华临床免疫和变态反应杂志,2018,12(1):14-18.
    [2]吕青青,吴爱惜,贾宵宵,等.支气管哮喘儿童皮肤点刺试验与血清sIgE的相关性分析[J].浙江临床医学,2018,20(4):621-623.
    [3]郑燕霞,刘卓勋,李冰洁,等.升气壮阳方联合标准化屋尘螨疫苗免疫治疗儿童变应性哮喘的临床疗效及安全性评价[J].实用医学杂志,2015(11):1855-1858.
    [4]李岚,骆翠媚,崔碧云,等.气道高反应性与屋尘螨特异性免疫治疗全身不良反应的相关性研究[J].护理实践与研究,2016,13(4):69-70.
    [5]吕青青,金小红,陈玲娇,等.支气管哮喘儿童青少年过敏原特点分析[J].预防医学,2017,29(11):1167-1169
    [6]刘晓莉,郑跃杰,闫卫娟,等.标准化屋尘螨变应原制剂在特异性免疫治疗中的不良反应观察[J].中国现代药物应用,2017,11(10):75-76.
    [7]郑佩燕,陈德晖,伍慧卿,等.屋尘螨变应原免疫治疗炎症细胞因子与特异性IgE和IgG4的动态相关分析[J].国际呼吸杂志,2016,36(13):961-966.
    [8]刘莲香,何莉,李燕芳.标准化免疫治疗对哮喘儿童屋尘螨特异性IgG4和肺功能的影响[J].中国当代医药,2015(26):91-93.
    [9]梁新,郝粉英,刘爱红,等.舌下含服粉尘螨滴剂治疗儿童过敏性哮喘的疗效、不良反应观察及护理[J].全科护理,2017,15(36):4524-4526.
    [10]郭淑云,林荣军.儿童呼吸困难评分(PRAM)对儿童哮喘控制的影响[J].临床医药文献电子杂志,2017,4(A4):20488.
    [11]王象勇,赵华,周毛,等.槐杞黄颗粒联合布地奈德福莫特罗治疗儿童咳嗽变异性哮喘的临床研究[J].现代药物与临床,2017,32(12):2392-2396.
    [12]黄连康.儿科哮喘治疗中孟鲁司特钠的临床效果观察[J].中外医学研究,2017,15(36):171-172.
    [13]李桂荣,李晗怡.冬病夏治穴位贴敷治疗儿童咳嗽变异性哮喘83例[J].西部中医药,2017,30(12):94-96.
    [14]楚喜田,李强.肺功能检查在儿童哮喘中的应用价值[J].实用心脑肺血管病杂志,2017,25(S2):90-91.